TITLE

Anti-VEGF injection improves PRP results in diabetic retinopathy

AUTHOR(S)
Loughery, Jessica
PUB. DATE
April 2008
SOURCE
Ocular Surgery News Europe/Asia-Pacific Edition;Apr2008, Vol. 19 Issue 4, p30
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article provides information on the impact of anti-vascular endothelial growth factor (VEGF) injection on panretinal photocoagulation (PRP) results in diabetic retinopathy. A study by Murat Oncel, found that administering intravitreal bevacizumab or anti-VEGF before PRP is more effective in treating diabetic retinopathy than treating with PRP alone because it enhanced the leakage reduction while preserving vision. An overview of PRP and its side effects is offered.
ACCESSION #
31655519

 

Related Articles

  • Anti-VEGF aids PRP in diabetic retinopathy.  // Ocular Surgery News Europe/Asia-Pacific Edition;Apr2008, Vol. 19 Issue 4, p1 

    The article provides information on anti-vascular endothelial growth factor (VEGF) and its ability to aid panretinal photocoagulation (PRP) in treating severe proliferative diabetic retinopathy. A combination of bevacizumab or Avastin and PRP was found to be more effective in the regression of...

  • Diabetic retinopathy: A growing concern in an aging population. Paulus, Yannis M.; Gariano, Ray F. // Geriatrics;Feb2009, Vol. 64 Issue 2, p16 

    The article focuses on diabetic retinopathy (DR), one of the complications of diabetes and a leading cause of irreversible blindness. Management of DR is offered which includes light laser treatment, the panretinal photocoagulation (PRP) laser treatment and the injection of anti-vascular...

  • Pathophysiology and treatment of diabetic retinopathy. Bandello, Francesco; Lattanzio, Rosangela; Zucchiatti, Ilaria; Turco, Claudia // Acta Diabetologica;Feb2013, Vol. 50 Issue 1, p1 

    In the past years, the management of diabetic retinopathy (DR) relied primarily on a good systemic control of diabetes mellitus, and as soon as the severity of the vascular lesions required further treatment, laser photocoagulation or vitreoretinal surgery was done to the patient. Currently,...

  • Laser photocoagulation remains option for diabetic macular edema. Bechtel, Bryan // Ocular Surgery News;8/10/2010, Vol. 28 Issue 15, p20 

    The article discusses laser photocoagulation as a viable option in the treatment of diabetic macular edema. The insufficiency of information on response to therapy in some patients has driven a search for alternative treatments that can deliver higher success rates, such as intravitreal...

  • Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy.  // Yonsei Medical Journal;1/1/2011, Vol. 52 Issue 1, p151 

    No abstract available.

  • Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network. Lik Thai Lim; Seen Nee Chia; Gupta, Manish; Ah-kee, Elliott Yann; Chew, Nejia // Singapore Medical Journal;May2015, Vol. 56 Issue 5, p237 

    The Diabetic Retinopathy Clinical Research Network (DRCR.net) performs studies on new treatments for diabetic retinopathy. This review aims to summarise recent findings from DRCR.net studies on the treatment of diabetic macular oedema. We performed a PubMed search of articles from the DRCR.net,...

  • Diabetic Papillopathy: Current and New Treatment Options. Giuliari, Gian P.; Sadaka, Ama; Chang, Peter Y.; Cortez, Rafael T. // Current Diabetes Reviews;May2011, Vol. 7 Issue 3, p171 

    Diabetes mellitus is a growing global epidemic. Patients with this disease present with a variety of health conditions, including a number of ocular complications that threaten vision, such as proliferative diabetic retinopathy and macular edema. Diabetic papillopathy, another potential ocular...

  • Systemic Medical Management of Diabetic Retinopathy. Lingam, Gopal; Tien Yin Wong // Middle East African Journal of Ophthalmology;Oct-Dec2013, Vol. 20 Issue 4, p301 

    Diabetes mellitus (DM) has assumed epidemic proportions and as a consequence, diabetic retinopathy is expected to be a major societal problem across the world. Diabetic retinopathy (DR) affects the vision by way of proliferative disease that results in vitreous hemorrhage and traction retinal...

  • Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema. Jovanović, Sandra; Čanadanović, Vladimir; Sabo, Ana; Grgić, Zorka; Mitrović, Milena; Rakić, Dušan // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Oct2015, Vol. 72 Issue 10, p876 

    Background/Aim. Within diabetic retinopathy (DR), diabetic macular edema (DME) is one of the leading causes of the loss of visual acuity. The aim of this study was to determine the efficacy of the intravitreal vascular endothelial growth factor (VEGF) inhibitor application alone or combined with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics